Comparison of the SeizCT Primer and Optimized Models for Predicting Positive Computed Tomography Findings in Patients With Non-Traumatic Seizures

SeizCT Primer模型与优化模型在预测非创伤性癫痫患者CT阳性结果方面的比较

阅读:2

Abstract

BACKGROUND: Previous studies developed the SeizCT primer and optimized models, both demonstrating similar values for the area under the receiver operating characteristic curve (AuROC). The optimized model incorporates Glasgow Coma Scale (GCS) change from baseline instead of categorized GCS at emergency department (ED) presentation. This study aimed to validate these two models for predicting positive computed tomography (CT) findings in patients with non-traumatic seizures. METHODS: A retrospective cross-sectional study was conducted among adult patients (≥ 18 years) with non-traumatic seizures who underwent CT brain imaging in the ED at Lampang Hospital. Data were collected between December 2023 and July 2024 based on parameters from the SeizCT primer and optimized models. External validation compared model performance using AuROC, calibration, decision curve analysis (DCA), and confusion matrices. RESULTS: The validation cohort included 312 patients (210 (67.3%) male; mean age 53 years). Positive CT findings were found in 58 patients (18.6%). The SeizCT primer model had an AuROC of 0.7218 (95% confidence interval (CI): 0.6476, 0.7961), while the SeizCT optimized model achieved 0.7394 (95% CI: 0.6663, 0.8124). An equivalence test showed statistically equivalent discrimination between the two models (P < 0.015), with the optimized model demonstrating better calibration (slope: 0.582 vs. 0.701; P = 0.002; observed-to-expected ratio: 0.934 vs. 0.971; P = 0.030). CONCLUSIONS: Both models demonstrated fair to acceptable discrimination after external validation. The SeizCT optimized model is recommended, as it showed superior calibration and its incorporation of GCS change from baseline offers greater clinical applicability.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。